Found: 34
Select item for more details and to access through your institution.
Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Response to the letter to the editor by Reilmann et al referring to our article titled "Motor cortex synchronization influences the rhythm of motor performance in premanifest Huntington's disease".
- Published in:
- 2018
- By:
- Publication type:
- Letter
Harnessing the power of placebos in movement disorders: Insights from Parkinson's disease in clinical research and practice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
On the rise: Quantitative measures in Huntington's disease.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Dopamine: Opening the door of movement.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The placebo response in Parkinson's disease and other movement disorders.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Progressive myoclonus ataxia: Time for a new definition?
- Published in:
- 2018
- By:
- Publication type:
- journal article
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes.
- Published in:
- 2018
- By:
- Publication type:
- Letter
α-Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Ataxia-telangiectasia: A review of movement disorders, clinical features and genotype correlations - Addendum.
- Published in:
- 2018
- By:
- Publication type:
- journal article
HPCA confirmed as a genetic cause of DYT2-like dystonia phenotype.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
What influences placebo and nocebo responses in Parkinson's disease?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Can heterozygotes of autosomal recessive disorders have clinical manifestations?
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Blood lysosphingolipids accumulation in patients with parkinson's disease with glucocerebrosidase 1 mutations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PBB3 binding in a patient with corticobasal syndrome.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
[<sup>18</sup> F]AV-1451 binding and postmortem pathology of CBD.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Pain processing in functional and idiopathic dystonia: An exploratory study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Proliferation of community exercise programs with limited evidence and expertise: Safety implications.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Understanding the new tremor classification.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ataxia-telangiectasia: A review of movement disorders, clinical features, and genotype correlations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
- Published in:
- 2018
- By:
- Publication type:
- journal article
6-n-propylthiouracil taste disruption and TAS2R38 nontasting form in Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
α-Synuclein strains in multiple system atrophy: A product of their environment?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Issue Information.
- Published in:
- Movement Disorders, 2018, v. 33, n. 8, p. 1, doi. 10.1002/mds.27159
- Publication type:
- Article
Placebo and nocebo responses in other movement disorders besides Parkinson's disease: How much do we know?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Disease-causing or benign? challenges in genetic variant interpretation and limitations of ClinVar.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Movement Disorders: Volume 33, Number 8, August 2018.
- Published in:
- Movement Disorders, 2018, v. 33, n. 8, p. 1, doi. 10.1002/mds.27456
- Publication type:
- Article
Why does the goalkeeper eschew medication? The challenge of new treatments for tourette syndrome.
- Published in:
- 2018
- By:
- Publication type:
- Editorial